Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis

Human Mutation
Sylvain HaneinJosseline Kaplan


Leber congenital amaurosis (LCA) is the earliest and most severe form of all inherited retinal dystrophies, responsible for congenital blindness. Disease-associated mutations have been hitherto reported in seven genes. These genes are all expressed preferentially in the photoreceptor cells or the retinal pigment epithelium but they are involved in strikingly different physiologic pathways resulting in an unforeseeable physiopathologic variety. This wide genetic and physiologic heterogeneity that could largely increase in the coming years, hinders the molecular diagnosis in LCA patients. The genotyping is, however, required to establish genetically defined subgroups of patients ready for therapy. Here, we report a comprehensive mutational analysis of the all known genes in 179 unrelated LCA patients, including 52 familial and 127 sporadic (27/127 consanguineous) cases. Mutations were identified in 47.5% patients. GUCY2D appeared to account for most LCA cases of our series (21.2%), followed by CRB1 (10%), RPE65 (6.1%), RPGRIP1 (4.5%), AIPL1 (3.4%), TULP1 (1.7%), and CRX (0.6%). The clinical history of all patients with mutations was carefully revisited to search for phenotype variations. Sound genotype-phenotype correlations were...Continue Reading


Nov 8, 1990·The New England Journal of Medicine·T P DryjaE L Berson
Oct 1, 1990·Human Genetics·J KaplanJ L Dufier
Mar 1, 1995·Ophthalmic Genetics·E I Traboulsi, I H Maumenee
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A NorthP M Nishina
Nov 5, 1997·Nature Genetics·F MarlhensC P Hamel
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·H MorimuraT P Dryja
Jul 24, 1998·Biochemical and Biophysical Research Communications·O OkladnovaK P Lesch
Oct 3, 1998·Brain Research. Molecular Brain Research·O OkladnovaK P Lesch
Nov 3, 1998·Human Genetics·D W StocktonJ R Lupski
Mar 26, 1999·American Journal of Human Genetics·I PerraultJ Kaplan
Oct 3, 1999·Nature Genetics·A I den HollanderA A Bergen
Jun 30, 2000·Molecular Genetics and Metabolism·M M SohockiS P Daiger
Aug 22, 2000·European Journal of Human Genetics : EJHG·I PerraultJ Kaplan
Mar 20, 2001·Archives of Ophthalmology·A J LoteryE M Stone
Apr 3, 2001·American Journal of Human Genetics·T P DryjaE L Berson
Jan 8, 2003·American Journal of Human Genetics·Dominique DucroqJosseline Kaplan
Apr 3, 2003·Experimental Biology and Medicine·Shelly A Waggoner, Stephen A Liebhaber
May 8, 2003·European Journal of Human Genetics : EJHG·T Jeffrey KeenChris F Inglehearn
Jan 1, 1963·Acta Ophthalmologica·P J WAARDENBURG, J SCHAPPERT-KIMMIJSER

❮ Previous
Next ❯


Feb 14, 2007·Archives of Ophthalmology·Stephen P DaigerLori S Sullivan
Dec 8, 2004·American Journal of Medical Genetics. Part a·Elisa FazziGiovanni Lanzi
May 26, 2007·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M N PreisingB Lorenz
Mar 7, 2006·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Leila El MatriFrancis L Munier
Dec 17, 2009·Molecular and Cellular Biochemistry·Sukanya KaranWolfgang Baehr
Oct 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gregory M AclandSamuel G Jacobson
Aug 30, 2008·Biochemistry·Grzegorz BeretaKrzysztof Palczewski
Jun 3, 2010·European Journal of Human Genetics : EJHG·Sibel A Ugur IseriAslihan Tolun
Feb 28, 2013·European Journal of Human Genetics : EJHG·Frida JonssonIrina Golovleva
Jan 21, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Frauke CoppietersElfride De Baere
Jul 26, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lolita PetitFabienne Rolling
Aug 9, 2007·European Journal of Human Genetics : EJHG·Sylvain HaneinMarc Jeanpierre
Jan 23, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jeannette BennicelliJean Bennett
Apr 29, 2008·The New England Journal of Medicine·Joan W Miller
Apr 29, 2008·The New England Journal of Medicine·James W B BainbridgeRobin R Ali
Oct 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rebecca LongbottomStephen E Moss
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Philip D KiserKrzysztof Palczewski
Jan 27, 2007·The Journal of Biological Chemistry·Wolfgang BaehrKrzysztof Palczewski
May 19, 2006·The British Journal of Ophthalmology·D M PaskowitzJ L Duncan
Mar 19, 2013·The British Journal of Ophthalmology·Arif O KhanFowzan S Alkuraya
Mar 11, 2008·Investigative Ophthalmology & Visual Science·Yogita KananAnne Kasus-Jacobi
Mar 3, 2009·The Journal of Clinical Investigation·Norann A Zaghloul, Nicholas Katsanis
May 25, 2011·The Journal of Clinical Investigation·José-Alain Sahel
Jul 3, 2008·BMC Veterinary Research·Anne Caroline WiikFrode Lingaas
Oct 13, 2006·Orphanet Journal of Rare Diseases·Christian Hamel
Feb 6, 2013·Orphanet Journal of Rare Diseases·Marta CortonCarmen Ayuso
Feb 12, 2014·PLoS Genetics·Nicholas M TranShiming Chen
Sep 26, 2013·PloS One·Anshuman VermaPeriasamy Sundaresan
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ronald RoepmanFrans P M Cremers
Sep 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqing LiuTiansen Li
Aug 7, 2014·Japanese Journal of Ophthalmology·Takahide SuzukiAkira Murakami

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.